Populus balsamifera extract and its active component salicortin reduce obesity and attenuate insulin resistance in a diet-induced obese mouse model

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Harbilas, Despina ^a,b,c   Vallerand, Diane ^a,b,c   Brault, Antoine ^a,b,c   Saleem, Ammar ^c,d   Arnason, John T ^c,d   Musallam, Lina ^a,b,c   Haddad, Pierre S ^a,b,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; GLUCOSE; LEPTIN; PLANT EXTRACT; POPULUS BALSAMIFERA EXTRACT; SALICORTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; FOOD INTAKE; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; INSULINEMIA; LIPID DIET; LIPID OXIDATION; LIVER; MALE; MOUSE; MUSCLE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RETROPERITONEAL FAT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84879299236     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/172537     Document Type: Article

References (64)

1. Robinson M. M., Zhang X., The World Medicines Situation 2011, Traditional Medicines: Global Situation, Issues and Challenges 2011 Geneva, Switzerland World Health Organization
2. Wallberg-Henriksson H., Zierath J. R., GLUT4: a key player regulating glucose homeostasis? Insights from transgenic and knockout mice (review). Molecular Membrane Biology 2001 18 3 205 211 2-s2.0-0034797496 10.1080/09687680110072131
3. Saltiel A. R., Kahn C. R., Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001 414 6865 799 806 2-s2.0-0035856949 10.1038/414799a
4. Kurth-Kraczek E. J., Hirshman M. F., Goodyear L. J., Winder W. W., 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 1999 48 8 1667 1671 2-s2.0-0032765396 10.2337/diabetes.48.8. 1667
5. Bouskila M., Hirshman M. F., Jensen J., Goodyear L. J., Sakamoto K., Insulin promotes glycogen synthesis in the absence of GSK3 phosphorylation in skeletal muscle. American Journal of Physiology 2008 294 1 E28 E35 2-s2.0-38349032866 10.1152/ajpendo.00481.2007
6. Petersen K. F., Cline G. W., Gerard D. P., Magnusson I., Rothman D. L., Shulman G. I., Contribution of net hepatic glycogen synthesis to disposal of an oral glucose load in humans. Metabolism 2001 50 5 598 601 2-s2.0-0035339682 10.1053/meta.2001.22561
7. Hwang J. T., Lee M. S., Kim H. J., Sung M. J., Kim H. Y., Kim M. S., Kwon D. Y., Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR- γ signal pathways. Phytotherapy Research 2009 23 2 262 266 2-s2.0-59449086814 10.1002/ptr.2606
8. Kimura A., Mora S., Shigematsu S., Pessin J. E., Saltiel A. R., The insulin receptor catalyzes the tyrosine phosphorylation of caveolin-1. The Journal of Biological Chemistry 2002 277 33 30153 30158 2-s2.0-0037119387
9. Augustin R., The protein family of glucose transport facilitators: It's not only about glucose after all. IUBMB Life 2010 62 5 315 333 2-s2.0-77953598589 10.1002/iub.315
10. Thorens B., Mueckler M., Glucose transporters in the 21st century. American Journal of Physiology 2010 298 2 E141 E145 2-s2.0-74949118966 10.1152/ajpendo.00712.2009
11. Fryer L. G. D., Parbu-Patel A., Carling D., The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. The Journal of Biological Chemistry 2002 277 28 25226 25232 2-s2.0-0037067666 10.1074/jbc.M202489200
12. Hardie D. G., Hawley S. A., Scott J. W., AMP-activated protein kinase-development of the energy sensor concept. Journal of Physiology 2006 574 1 7 15 2-s2.0-33745225026 10.1113/jphysiol.2006.108944
13. Nordlie R. C., Foster J. D., Lange A. J., Regulation of glucose production by the liver. Annual Review of Nutrition 1999 19 379 406 2-s2.0-0032797852 10.1146/annurev.nutr.19.1.379
14. Al-Daghri N., Bartlett W. A., Jones A. F., Kumar S., Role of leptin in glucose metabolism in type 2 diabetes. Diabetes, Obesity and Metabolism 2002 4 3 147 155 2-s2.0-0036262353 10.1046/j.1463-1326.2002.00194.x
15. Williams K. W., Scott M. M., Elmquist J. K., From observation to experimentation: leptin action in the mediobasal hypothalamus. American Journal of Clinical Nutrition 2009 89 3 985S 990S 2-s2.0-61449129183 10.3945/ajcn.2008.26788D
16. Díez J. J., Iglesias P., The role of the novel adipocyte-derived hormone adiponectin in human disease. European Journal of Endocrinology 2003 148 3 293 300 2-s2.0-0037356826 10.1530/eje.0.1480293
17. Nedvídková J., Smitka K., Kopský V., Hainer V., Adiponectin, an adipocyte-derived protein. Physiological Research 2005 54 2 133 140 2-s2.0-18844409132
18. Vasseur F., Leprêtre F., Lacquemant C., Froguel P., The genetics of adiponectin. Current Diabetes Reports 2003 3 2 151 158 2-s2.0-0038545484
19. Rasouli N., Kern P. A., Adipocytokines and the metabolic complications of obesity. Journal of Clinical Endocrinology and Metabolism 2008 93 11 s64 s73 2-s2.0-55849114349 10.1210/jc.2008-1613
20. Considine R. V., Sinha M. K., Heiman M. L., Kriauciunas A., Stephens T. W., Nyce M. R., Ohannesian J. P., Marco C. C., Mckee L. J., Bauer T. L., Caro J. F., Serum immunoreactive-leptin concentrations in normal-weight and obese humans. The New England Journal of Medicine 1996 334 5 292 295 2-s2.0-13344295079 10.1056/NEJM199602013340503
21. Kumar S., Obesity and Diabetes 2009 John Wiley & Sons
22. Shulman G. I., Cellular mechanisms of insulin resistance. The Journal of Clinical Investigation 2000 106 2 171 176 2-s2.0-0033927667
23. Farmer S. R., Regulation of PPARgamma activity during adipogenesis. International Journal of Obesity 2005 29 supplement 1 S13 S16
24. Endemann G., Stanton L. W., Madden K. S., Bryant C. M., White R. T., Protter A. A., CD36 is a receptor for oxidized low density lipoprotein. The Journal of Biological Chemistry 1993 268 16 11811 11816 2-s2.0-0027280397
25. Nicholson A. C., Frieda S., Pearce A., Silverstein R. L., Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 2 269 275 2-s2.0-0028963942
26. Baxa C. A., Sha R. S., Buelt M. K., Smith A. J., Matarese V., Chinander L. L., Boundy K. L., Bernlohr D. A., Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA. Biochemistry 1989 28 22 8683 8690 2-s2.0-0024441333
27. Arkan M. C., Hevener A. L., Greten F. R., Maeda S., Li Z. W., Long J. M., Wynshaw-Boris A., Poli G., Olefsky J., Karin M., IKK- β links inflammation to obesity-induced insulin resistance. Nature Medicine 2005 11 2 191 198 2-s2.0-20044387026 10.1038/nm1185
28. Porstmann T., Griffiths B., Chung Y. L., Delpuech O., Griffiths J. R., Downward J., Schulze A., PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 2005 24 43 6465 6481 2-s2.0-26244464326 10.1038/sj.onc.1208802
29. Ntambi J. M., Miyazaki M., Stoehr J. P., Lan H., Kendziorski C. M., Yandell B. S., Song Y., Cohen P., Friedman J. M., Attie A. D., Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proceedings of the National Academy of Sciences of the United States of America 2002 99 17 11482 11486 2-s2.0-0037143752 10.1073/pnas.132384699
30. Chen N., Bezzina R., Hinch E., Lewandowski P. A., Cameron-Smith D., Mathai M. L., Jois M., Sinclair A. J., Begg D. P., Wark J. D., Weisinger H. S., Weisinger R. S., Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutrition Research 2009 29 11 784 793 2-s2.0-70449675075 10.1016/j.nutres.2009.10.003
31. Chavez-Tapia N. C., Mendez-Sanchez N., Uribe M., Role of nonalcoholic fatty liver disease in hepatocellular carcinoma. Annals of Hepatology 2009 8 supplement 1 S34 S39 2-s2.0-66749091560
32. Bost F., Aouadi M., Caron L., Binétruy B., The role of MAPKs in adipocyte differentiation and obesity. Biochimie 2005 87 1 51 56 2-s2.0-14544298335 10.1016/j.biochi.2004.10.018
33. Donzelli E., Lucchini C., Ballarini E., Scuteri A., Carini F., Tredici G., Miloso M., ERK1 and ERK2 are involved in recruitment and maturation of human mesenchymal stem cells induced to adipogenic differentiation. Journal of Molecular Cell Biology 2011 3 2 123 131 2-s2.0-79953890909 10.1093/jmcb/mjq050
34. WHO, Obesity Prevalence in the Aboriginal Canadian Population 2004
35. WHO, Obesity Prevalence in the Canadian Population 2004
36. Dannenbaum D., Kuzmina E., Bay rBoHaSSoJ, J. T. clinical management of diabetes in Eeyou Istchee-2009. Internal Report For Healthcare Workers 2010 Quebec, Canada Public Health Report Series 3 on Diabetes
37. Harbilas D., Martineau L. C., Harris C. S., Adeyiwola-Spoor D. C. A., Saleem A., Lambert J., Caves D., Johns T., Prentki M., Cuerrier A., Arnason J. T., Bennett S. A. L., Haddad P. S., Evaluation of the antidiabetic potential of selected medicinal plant extracts from the Canadian boreal forest used to treat symptoms of diabetes: part II. Canadian Journal of Physiology and Pharmacology 2009 87 6 479 492 2-s2.0-67449116853 10.1139/Y09-029
38. Martineau L. C., Hervé J., Muhamad A., Saleem A., Harris C. S., Arnason J. T., Haddad P. S., Anti-adipogenic activities of Alnus incana and Populus balsamifera bark extracts, part I: sites and mechanisms of action. Planta Medica 2010 76 13 1439 1446 2-s2.0-77956705076 10.1055/s-0029-1240941
39. Martineau L. C., Muhammad A., Saleem A., Hervé J., Harris C. S., Arnason J. T., Haddad P. S., Anti-adipogenic activities of alnus incana and populus balsamifera bark extracts, part II: bioassay-guided identification of actives salicortin and oregonin. Planta Medica 2010 76 14 1519 1524 2-s2.0-77956688451 10.1055/s-0029-1240991
40. Kim J. K., Kim Y. J., Fillmore J. J., Chen Y., Moore I., Lee J., Yuan M., Li Z. W., Karin M., Perret P., Shoelson S. E., Shulman G. I., Prevention of fat-induced insulin resistance by salicylate. The Journal of Clinical Investigation 2001 108 3 437 446 2-s2.0-0034903710 10.1172/JCI200111559
41. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z. W., Karin M., Shoelson S. E., Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikk β Science 2001 293 5535 1673 1677 2-s2.0-0035979775 10.1126/science.1061620
42. Zheng L., Howell S. J., Hatala D. A., Huang K., Kern T. S., Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes 2007 56 337 345
43. Subramanian B., Nakeff A., Tenney K., Crews P., Gunatilaka L., Valeriote F., A new paradigm for the development of anticancer agents from natural products. Journal of Experimental Therapeutics and Oncology 2006 5 3 195 204 2-s2.0-33646678195
44. Harbilas D., Brault A., Vallerand D., Populus balsamifera L. (Salicaceae) mitigates the development of obesity and improves insulin sensitivity in a diet-induced obese mouse model. Journal of Ethnopharmacology 2012 141 1012 1020
45. Buettner R., Schölmerich J., Bollheimer L. C., High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 2007 15 4 798 808 2-s2.0-34248393099 10.1038/oby.2007.608
46. Collins S., Martin T. L., Surwit R. S., Robidoux J., Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiology and Behavior 2004 81 2 243 248 2-s2.0-2442710044 10.1016/j.physbeh.2004.02.006
47. Peyot M. L., Pepin E., Lamontagne J., Latour M. G., Zarrouki B., Lussier R., Pineda M., Jetton T. L., Madiraju S. R. M., Joly E., Prentki M., β -cell failure in diet-induced obese mice stratified according to body weight gain: secretory dysfunction and altered islet lipid metabolism without steatosis or reduced β -cell mass. Diabetes 2010 59 9 2178 2187 2-s2.0-77956373690 10.2337/db09-1452
48. Folch J., Lees M., Sloane Stanley G. H., A simple method for the isolation and purification of total lipides from animal tissues. The Journal of Biological Chemistry 1957 226 1 497 509 2-s2.0-70449158340
49. Egan C. D., Addressing use of herbal medicine in the primary care setting. Journal of the American Academy of Nurse Practitioners 2002 14 4 166 171 2-s2.0-0036550813
50. Leduc C., Coonishish J., Haddad P., Cuerrier A., Plants used by the Cree Nation of Eeyou Istchee (Quebec, Canada) for the treatment of diabetes: a novel approach in quantitative ethnobotany. Journal of Ethnopharmacology 2006 105 1-2 55 63 2-s2.0-33645319705 10.1016/j.jep.2005.09.038
51. Fraser M. H., Cuerrier A., Haddad P. S., Arnason J. T., Owen P. L., Johns T., Medicinal plants of cree communities (Québec, Canada): antioxidant activity of plants used to treat type 2 diabetes symptoms. Canadian Journal of Physiology and Pharmacology 2007 85 11 1200 1214 2-s2.0-38849165832 10.1139/Y07-108
52. Ye J. M., Doyle P. J., Iglesias M. A., Watson D. G., Cooney G. J., Kraegen E. W., Peroxisome proliferator-activated receptor (PPAR)- α activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats. Comparison with PPAR- γ activation. Diabetes 2001 50 2 411 417 2-s2.0-0035141142
53. Girard J., Lafontan M., Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: visceral adipose tissue production and liver metabolism. Diabetes and Metabolism 2008 34 5 439 445 2-s2.0-55949114663 10.1016/j.diabet.2008.04.002
54. den Boer M., Voshol P. J., Kuipers F., Havekes L. M., Romijn J. A., Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 4 644 649 2-s2.0-1842580567 10.1161/01.ATV.0000116217.57583.6e
55. Nachar A., Saleem A., Vallerand D., Beneficial effects in the liver of antidiabetic plants used in traditional medicine by the Cree of Bay James in Canada. Proceedings of the 10th Annual Oxford International Conference on the Science of Botanicals 2011 Mississipi, Miss, USA Planta Medica
56. Tilg H., Moschen A. R., Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010 52 5 1836 1846 2-s2.0-78049522194 10.1002/hep.24001
57. Luther J., Driessler F., Megges M., Hess A., Herbort B., Mandic V., Zaiss M. M., Reichardt A., Zech C., Tuckermann J. P., Calkhoven C. F., Wagner E. F., Schett G., David J. P., Elevated Fra-1 expression causes severe lipodystrophy. Journal of Cell Science 2011 124 9 1465 1476 2-s2.0-79955531027 10.1242/jcs.079855
58. Stanton M. C., Chen S. C., Jackson J. V., Rojas-Triana A., Kinsley D., Cui L., Fine J. S., Greenfeder S., Bober L. A., Jenh C. H., Inflammatory signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice. Journal of Inflammation 2011 8, article 8 2-s2.0-79952698689 10.1186/1476-9255-8-8
59. Walshe-Roussel B., Saleem A., Cieniak C., Guerrero J. A., Muhammad A., Haddad P., Arnason J. T., Phytochemical profiling and immunomodulatory activity of water and ethanol extracts from Cree of Eeyou Istchee anti-diabetic botanicals. Joint Meeting with American Society of Pharmacognosy-Phytochemical Society of North America (ASP-PSNA '10) 2010 Florida, Fla, USA
60. Zick Y., Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. Trends in Cell Biology 2001 11 11 437 441 2-s2.0-0035500813 10.1016/S0962-8924(01)02129-8
61. Arnason J. T., Hebda R. J., Johns T., Use of plants for food and medicine by native peoples of Eastern Canada. Canadian Journal of Botany 1981 59 2189 2325
62. Marles R. J., Clavelle C., Monteleone L., Tays N., Burns D., Aboriginal Plant Use in Canada's Northwest Boreal Forest 2000 Vancouver, Canada UBC Press
63. Leighton A. L., Wild Plant Use By the Woods Cree (Nihithawak) of East-Central Saskatchewan 1985 Ottawa, Canada National Museums of Canada
64. Efferth T., Koch E., Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Current Drug Targets 2011 12 1 122 132 2-s2.0-78650912735 10.2174/138945011793591626